Screening assays in 384-well plate format using airway organoids have been previously been described by others [24,25,26] and our protocol was based on a 384-well screening assay for CFTR-modulating drugs in CF intestinal organoids [27]. This evidence concerns the gene CFTR and cystic fibrosis.